Esperion Therapeutics Inc.的合作伙伴Otsuka已获得日本监管部门批准,可在日本市场销售Nexletol®,用于治疗高胆固醇血症。
Esperion Therapeutics Inc.的合作伙伴Otsuka已获得日本监管部门批准,可在日本市场销售Nexletol®,用于治疗高胆固醇血症。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.